
Agreement - July 1, 2019
Photocure enters global licensing deal
The company has entered into a License Agreement providing Asieris Meditech with a world-wide license to develop and commercialize Cevira for the treatment of HPV induced cervical precancerous lesions. Asieris plans to launch a global clinical development program with an initial focus on the China market based on Photocure’s Phase 2b data and the Phase […]